Form 10-Q · Quarterly report
Ball Corporation 10-Q, filed Nov 3, 2026
- Filed
- CIK
- 0000009389
- Accession no.
- 0001104659-26-121838
Summary
Ball Corporation's third-quarter 2026 net sales increased to $4.188 billion from $3.379 billion a year earlier, while net earnings attributable swung to a $94 million loss from $321 million profit, primarily due to a $475 million noncash settlement charge for a U.K. defined benefit pension plan buy-out.
Key points
- Ball's third-quarter 2026 net sales rose $809 million, driven mainly by price/mix from higher aluminum prices and higher volume.
- Third-quarter net earnings attributable decreased $415 million to a $94 million loss, primarily from the $475 million noncash U.K. pension buy-out settlement charge.
- For the nine months ended September 30, 2026, net sales were $11.788 billion and net earnings attributable were $332 million, compared with $9.814 billion and $712 million in the same period of 2025.
- Business consolidation and other activities in the third quarter of 2026 included the pension charge and previously announced facility closure costs, partly offset by a reversal of tariff contingencies after a favorable U.S. Department of Commerce ruling.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. MANAGEMENT’S DISCUSSION OVERVIEW Business Overview and Industry Trends Ball Corporation is one of the world’s leading aluminum packaging suppliers. With a growth mindset and by pursuing operational excellence, we lean on our competitive strengths to reach our financial goals. We are focused on maintaining our strong financial position by listening to and partnering with our global customers, delivering operational efficiencies and an innovative product portfolio from our best-in-class manufacturing facilities and returning value to shareholders via share repurchases and dividends. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.